找回密碼
 To register

QQ登錄

只需一步,快速開始

掃一掃,訪問微社區(qū)

打印 上一主題 下一主題

Titlebook: Melanoma; Howard L. Kaufman,Janice M. Mehnert Book 2016 Springer International Publishing Switzerland 2016 Diagnosis.Immunotherapy.Melanom

[復制鏈接]
樓主: Hayes
41#
發(fā)表于 2025-3-28 17:21:16 | 只看該作者
42#
發(fā)表于 2025-3-28 19:02:57 | 只看該作者
43#
發(fā)表于 2025-3-29 02:21:36 | 只看該作者
Melanoma Epidemiology and Prevention,well. Sun exposure can be classified as intermittent, chronic, or cumulative (overall) exposure, and each appears to have a different effect on type of melanoma. Other environmental factors, such as chemical exposures—either through occupation, atmosphere, or food—may increase risk for melanoma, and
44#
發(fā)表于 2025-3-29 05:17:18 | 只看該作者
45#
發(fā)表于 2025-3-29 08:39:40 | 只看該作者
Melanoma: Clinical Presentations,on the skin. However, melanoma can also arise on mucosal surfaces such as the oral cavity, the upper gastrointestinal mucosa, the genital mucosa, as well as the uveal tract of the eye and leptomeninges. Melanomas tend to be pigmented but can also present as pink or red lesions. They can mimic benign
46#
發(fā)表于 2025-3-29 14:10:36 | 只看該作者
Principles of Melanoma Staging,system is a relatively modern concept. Overall, the goals of cancer staging are to characterize the status of cancer at a specific moment in time, risk stratify, facilitate prognostication, and inform clinical decision making. The revisions to the American Joint Committee on Cancer (AJCC) melanoma s
47#
發(fā)表于 2025-3-29 16:12:45 | 只看該作者
48#
發(fā)表于 2025-3-29 23:25:29 | 只看該作者
Adjuvant Therapy of Melanoma, melanoma tumorigenesis have established roles for inhibitors of the MAPK pathway and regulatory immune checkpoints CTLA-4 and PD-1/PD-L1. However, the majority of patients continue to present with non-metastatic disease—typically managed with surgical resection and adjuvant therapy. High-dose IFN-α
49#
發(fā)表于 2025-3-30 00:20:48 | 只看該作者
50#
發(fā)表于 2025-3-30 05:58:18 | 只看該作者
Checkpoint Blockade for the Treatment of Advanced Melanoma,nt inhibition has been most extensively studied in patients with advanced melanoma and there are three FDA approved antibodies already widely used in clinical practice (ipilimumab, nivolumab, and pembrolizumab). In this chapter, we review the mechanistic basis behind the development of immune checkp
 關于派博傳思  派博傳思旗下網(wǎng)站  友情鏈接
派博傳思介紹 公司地理位置 論文服務流程 影響因子官網(wǎng) 吾愛論文網(wǎng) 大講堂 北京大學 Oxford Uni. Harvard Uni.
發(fā)展歷史沿革 期刊點評 投稿經(jīng)驗總結(jié) SCIENCEGARD IMPACTFACTOR 派博系數(shù) 清華大學 Yale Uni. Stanford Uni.
QQ|Archiver|手機版|小黑屋| 派博傳思國際 ( 京公網(wǎng)安備110108008328) GMT+8, 2026-1-24 14:45
Copyright © 2001-2015 派博傳思   京公網(wǎng)安備110108008328 版權所有 All rights reserved
快速回復 返回頂部 返回列表
宜黄县| 桓仁| 沾化县| 波密县| 交口县| 仲巴县| 梁河县| 靖州| 濮阳市| 乌兰察布市| 浙江省| 鹤山市| 福州市| 怀集县| 交口县| 苗栗县| 磴口县| 黄平县| 湄潭县| 崇信县| 福建省| 株洲县| 合川市| 武乡县| 沿河| 五华县| 三明市| 道真| 嘉祥县| 桂林市| 麟游县| 五大连池市| 南和县| 万宁市| 泊头市| 芦溪县| 临洮县| 望谟县| 桂阳县| 秦皇岛市| 连平县|